Medical devices, healthcare technology and the business of care
PMA approval · P020036

S.M.A.R.T. AND S.M.A.R.T. CONTROL NITINOL STENT SYSTEM

Cordis US Corporation · Decision date Aug 12, 2003

MEDTECHLEDGER EXPLANATIONP020036

What did the FDA approve?

The FDA database entry records an August 12, 2003 approval for the S.M.A.R.T. Nitinol Stent System and S.M.A.R.T. Control Nitinol Stent System from Cordis US Corporation. The stated purpose is improving luminal diameter in patients with symptomatic atherosclerotic disease of the common and/or external iliac arteries up to 126 mm in length, with a reference vessel diameter of 4 to 9 mm, and angiographic evidence of a patient profunda or superficial femoral artery.

This is an original PMA approval, not a supplement or manufacturing notice. The entry does not describe a changed item or a relationship to a prior PMA. The statement reports the approved indication as written in the database; it does not independently establish safety or clinical effectiveness. No trial data, technical specifications, or clinical benefit assessments appear in the source fields.

FDA approval order statement

APPROVAL FOR THE S.M.A.R.T. NITINOL STENT SYSTEM AND S.M.A.R.T. CONTROL NITINOL STENT SYSTEM. THE DEVICES ARE INDICATED FOR IMPROVING LUMINAL DIAMETER IN PATIENTS WITH SYMPTOMATIC ATHEROSCLEROTIC DISEASE OF THE COMMON AND/OR EXTERNAL ILIAC ARTERIES UP TO 126 MM IN LENGTH, WITH A REFERENCE VESSEL DIAMETER OF 4 TO 9 MM, AND ANGIOGRAPHIC EVIDENCE OF A PATIENT PROFUNDA OR SUPERFICIAL FEMORAL ARTERY.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Aug 12, 2003

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P020036
Regulatory pathway
Premarket approval application
Product code
NIO
Decision code
APPR
Decision date
Aug 12, 2003
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, ILIAC.

Product code
NIO
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P020036 received

    Application receipt date recorded by FDA.

  2. P020036 · FDA decision

    APPR

  3. P020036/S061 · Related supplement

    S.M.A.R.T. CONTROL Nitinol Stent System

Timeline entries are records held by MedtechLedger for P020036. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P020036

Product / regulatory recordCompanyPathwayDecision dateSource
Cordis US CorporationPMA supplementOct 15, 2026FDA

Explore the linked device profile

Other records with product code NIO

Product / regulatory recordCompanyPathwayDecision dateSource
Cook Ireland, Ltd.PMA supplementNov 6, 2026FDA
Medtronic Vascular, Inc.PMA supplementOct 16, 2026FDA
Biotronik AGPMA supplementSep 11, 2026FDA
Biotronik AGPMA approvalDec 17, 2015FDA
Cook Ireland, Ltd.PMA approvalJun 26, 2006FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cordis US Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
14201 NW 60th Ave., Miami Lakes, FL, 33014

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records